[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"1df52e3e3bbde7842df035d93e38bc5c14fc33387915b265a4502201d8a58125","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"1df52e3e3bbde7842df035d93e38bc5c14fc33387915b265a4502201d8a58125","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"4e46b7f575dea1854b3e46fa8cf538a68ef0f2453ecab53e181ce60da35f0369","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"25eb6ae3fa0eeafdce286ed505bac50de31cea6d95fc26a404f638a52c642171","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Identify drugs, their therapeutic use, and side effects based on drug name and structure\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Use pharmacophoric drug models to predict potency, metabolism, or side effects\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Apply mechanisms of drug/xenobiotic biotransformation to parent drugs\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Explain factors affecting drug/xenobiotic metabolism in humans, including both environmental and genetic effects and the resulting clinical implications\"}]"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"fba2bad5a726f61096b72a656836f6f304dbfd12b2f273e480dbb8769e502607","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"fba2bad5a726f61096b72a656836f6f304dbfd12b2f273e480dbb8769e502607","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"a6ffa452475b5cadf78ee074e743bfd9b8711741496d06301a7cc5d49e48f368","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"4a45ec470ae8749fde96a2d2adae57f87f44c892f96aec585313b726ca641f29","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"b82b99ba0f31cc7b680b57b88a8e6636a307d4cb2226db5b5e2d17269a50ab98","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"988ba77575639708f76bdbb819ab16a7d8d22d71d18e43aa638c9c5324e41aba","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"3957d0f1cbaa599962c1b25fbfd8bff9348ece578feba73d681fc25b5790feb0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"bb7972f2bed924bb2866e75177c7ab29d96371510b030e635e922b0e09f3a445","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"e96a54279af5de486347235b9ad609f1120955bce35f6fe86883dfdab33c4aa4","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"4d5f2c8475e5d8cab0431dff68b18be2c2d795aa4ed21e79ccb5692d684af0c1","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"e3542bb57565a0f3d10733336d269af745ed28a47922d9b5400c0675b88fece1","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"47f1b9071bf6c286b93cb4ca7da8faf42e77b0ae5d877d0c1e43c4d01b79d002","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"47e2fb6eee543bd791e5dd51725a57c389521ee2a4d75f7cedd3c0ee6bd074a3","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"e1b934d535cb18c81bf78c721f5cd88f043371f17699d52d1cd00247129579e0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"e44d0355de2bb151675680888151a7696d2fd92a66dc0e90dd20f10b6f37adf7","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"f855c2b275ee68a0777d9c15529b039578d141417e308d60066a09397f3cc217","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"987d4895cd1115a72fb5cddab42c3d49c77f06638e0af25f21f8207fbe4cb879","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"6d4e58dcc1b559750d2a8d670492f0ea60f5f62806c7c35cc45b0c2bc80bba47","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"68ac32ae0e3850661d4b9047d878a96ffc431c898c6944fae2f70c62c1565c0c","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"8f4736618606c1390e689101fc561ec9e6715600598e85d0cb65ada15f1175e2","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"1e0efd05abee77cfd9d79df9f48a3250c371d6be8869d6d56225c97bb7f2a8e0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"2c1860021b923ddf5bd766d4c0bf9c727016fbb51437f75b0de65e0d7f764c51","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"5b40b632012c36f07ddfe1cdf0ba18af8eec3f93b2a5c81c2dc70f2a537733c2","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"8147e6535c3deb47b2b8e429def13f2a22db5cb78ab26df2d21a80ee4956337d","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"8cf4892fa5953cdcb4b294feaab14ae1bc71bd7b2eb66d1c3a92e2213d4cc57e","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"66d725df9015a959f6e594c30717dd29a75831ff3a2afcc6494636240893a2d5","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"4bfb6d8f794758b552a58d4137f20917053127035d0b2545531cfedec6d3d9a6","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"e560ce85f05f4566852c5f97bff059f03939f01cb44c0d08e0a070a45559cb1f","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"efe26ff0562410c3511fb216c942510087f9f018304d25554759a9b57a7eb15e","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"15dd3700417e0420006e6ea6b37517047da900ee468cd77846190eb9de954d28","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"a5d1dfa621420fc621f26e8b9df1671a2198009a559de5d6a6ab6e22629b2df4","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"2192d6be7f37a1f6fd42d8c5102a106411609da55bbfa3bd9624dc6bf6d63092","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"03533fb61ff52a55c8ae1e263c17ae867ec2e084816319f40a56e0c5913958d8","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"992b9c945fab5209f211379b1469e08fdfa2e9ed52b849bc67ec563329abf0d2","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"8139a0e33047f17123a14e0af3791aaf2790f43a8555f0fa76ed7e42ecac6130","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"70543380c03bc72b8cac2d0915b9c84a35d5c51a641ba5a3da9e1ec2dd3387a0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"d081ba7481fdcd344eddae3b7ae87d1e7647fc85b60a1171ef0dc2f56fade07b","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"8eafddc8ca6285f231c7a34240da2f82102ebf0f2772f400975e5f3c0a057c10","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"35ba59942d83447aaeb1c91f85b5ba2f469aa2546a25615a55ae689af908492c","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"36a63f2bddb210603e174d6c8c1d9c1e49fd0c0e0ffb9e841df89ddc54c04fce","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"a33cf0077e3a34f025a2ac04e1aeed0f3c447340f81d1033359653e79c57b5c8","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"6258c8fec66689c951d29e4be75c85236a213e1997edf1aaf8df8c691544f6b5","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"dda861b7e0330107812b11f3f57d2f8a8d4484d6fc566ec4430bf24a811ab48d","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"5d31188b718c368a0dee34ce27ea57f389f241ab93461fd9c7fdc60b289dcc32","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"cc296c35ea43c355ec03a4d2ce70ffbc13b7795078492d766708d657223c7822","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"109e2f49ec377a3dc14dac5e62ccbd71a481f6f98892f7d186ec9a4ba111fca0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"709b74d9d4aaab760e5817a346782e03455bbf4dc2d244bd6a3e16e79f78d333","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"e1f78fc300abd2a6bcc396f9f4d81f5f195df2f782063546d101bcddcc9fbe71","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"778037945b341eb9f719b8bafe000187ef7778ecc2a08dcd1fcd980a275bcead","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"0789dc3c86ab3f72d994991690a61407cb38c9bfa50cdfafa1de59fdf375d1b3","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"cb0b756cc98fdaa6d2bb3b46bbb43aec449b92bc7354273f30bf072cae909e0d","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"fbe51b8ca21bb633279e740a5c79ec58693bedee6d745471475d94c71d90b3ea","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"464b84783b6c438912f367c9bae42eb2d260910b37bdfe869377ffc595864ea1","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"380acc13da2a5f21cbf9bf7feefca66c0ce9e2db1dac9e3115e49fb330584b2e","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"bc742d7e3dc27e30d120c3bc189f4cffd78ea04d8a59a36298c6729025f9b5ea","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"17a404629bd9ac7207440132ae2c307d9f0a566c26de009d37dc677c9ef398e1","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"d43aafe369b936d3fb2de59c3aae5c0eb91a6fde74294c4de5598574051ba747","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"2d819668fc1522b332dcb31e36fd48b8b5235a3a24bfbb360be70dd25ea0a1dc","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"5b0e8609c3d15ae1ac53b7c60f518169f9168e700f26dfe0ecd788c3d069c9d9","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"0865cc538f982d18b0ad23338f67213c0e5eeda4a1a70fe573805929fddd94bb","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"919b7930c4006b95630f58aed6301559d5e1a5481e3b6d10afe0b1547f41b745","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"e57af1b5a5877c5f3bf0785bcadef8262c323c2879edf1fb98c3fc45e566f5fa","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"237a764f3b88efc07c81d8b2e7921fd1d6ec1139190c90827987ea4be7df9b8f","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"7c0e3f898198ad6a620bc052198e157e3eeaab9a3734b88495beaec9d6ba2612","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"cc296c35ea43c355ec03a4d2ce70ffbc13b7795078492d766708d657223c7822","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"5def1bc450959aba9bf939f6614091141a107bdb7ecf8cae7fe2ad6ecbe0dd39","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"a7a8ce2dec680b53f4a96a0fe3fea4c5d122a5bcc9b5e3fd69f77b504b8e4e36","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"1ecbb18477aa20bee92db32568062c17e9ad14e3afc5bb2daf534f2b90ef9b1e","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"c923732da582bea2e274fa647c80994add3f3cd29f97ac36ee0b9cc753dc9c7a","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"4d18f0ae6009bab5be391a77e4894418fd296914ad28b3605fbd28d42b0bb2e0","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"b75139ace4a507c867c17899d02369f193a38ddf810180bf91984daea3959766","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"06490b4205d606af807188c60f47e845f90437d70e4143325237031b35547819","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"98bb540144a32ad86ec019b3b00a3e076a8195e81145804f72560e9fd6183466","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"e56d021ec64df937208e5e2a82024f1ca9dcd47a8c6888f9bd25f6d61813e353","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"f995b0b14b32be539c6307f8406a2dc8e30221d312e9072c7bcff6ef7be1f888","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"82d820e04ca7288e477b82f2c6269bde6443eec8fcf133b7c7c17c06c8470bd5","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"8b899cdf6ff3c13ca9217d8a69c4afcaff1ecd45e9767e4fdf853184b3f6e023","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"a79d43f9e5df9327cb81c749a356b54b61fb4e71ec6ad86e8302bad294433a3d","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"46f0597e1d74e3460300e7f324ab0ea9aa6c37a98e72e120fb67c68a142cd563","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"6003a85286578dab19b100e6b5ffeaac00e02b7b0bdca7f687a75a0b6adf3457","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"f3ab9d0a4a1f87c8a9a45172c869da2dff5ca7deec6c735926a0261b2fc8a89c","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"bcdfe9066b040e648e37b86899c2e0556045a05225f6bcc4bf1fefe681d05671","course_id":"PHMSCI 531","course_uid":"course_9e16b17aaf841286719019d6","catalog_version_id":"8528527ed011a6c176d2e983e501162a053fda5fdd55478d999e35bd7d2c4974","course_number":531,"subjects":["PHMSCI"],"title":"MEDICINAL CHEMISTRY I","description":"Basic concepts in the chemistry of small molecule medicinal products. Structure activity of cholinergic, adrenergic, serotonergic and dopaminergic agents, antidepressant, antianxiety drugs, opioids, and antihistamines. Overview of drug metabolism and the clinical effects of metabolic drug interactions and genetic variability in drug metabolism genes.","requirements_text":"PHM SCI 432","official_learning_outcomes_json":"[]"}]